Mcg to Mg Converter for Peptides

For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Convert micrograms to milligrams and back, live and in both directions. One fixed fact does all the work: 1 mg = 1000 mcg. Type into either box and the other updates instantly — exact arithmetic, any value.

1 mg = 1000 mcg · mg = mcg ÷ 1000 · mcg = mg × 1000

Peptide vials and research protocols switch between two units of mass without much warning: micrograms (mcg, sometimes written µg) and milligrams (mg). A vial might be labelled “10 mg,” a protocol might specify a “250 mcg” dose, and a reconstitution calculator might ask for the amount in milligrams — three units, one quantity. This converter does the single job that keeps those numbers aligned: it turns micrograms into milligrams and milligrams into micrograms, live and in both directions, so a decimal never lands in the wrong place.

The relationship is fixed: 1 milligram equals 1000 micrograms. That one fact drives everything on this page. To convert micrograms to milligrams you divide by 1000; to convert milligrams to micrograms you multiply by 1000. Type a value into either box in the tool above and the other updates instantly.

Why micrograms and milligrams both show up in peptide work

Research peptides are supplied as a lyophilised (freeze-dried) powder, and the vial is almost always labelled by its total mass in milligrams — a 5 mg vial, a 10 mg vial, and so on. Individual research doses, however, are frequently a small fraction of a milligram, so they are quoted in micrograms to avoid a string of leading zeros: it is easier to read “250 mcg” than “0.25 mg.” Both describe the exact same amount.

The trouble starts when the two units are treated as interchangeable numbers. Reading a 250 mcg figure as “250 mg,” or entering milligrams into a field that expects micrograms, is a 1000-fold error — the difference between 0.25 mg and 250 mg. Converting first, deliberately, removes that failure mode. That is the entire reason this tool reports the equation (for example, 250 mcg = 0.25 mg) rather than just swapping a number: it keeps the unit attached to the value.

How to convert mcg to mg (and back)

Because the factor is exactly 1000, every conversion is a decimal-point move of three places — no calculator strictly required once you see the pattern:

mcg → mg: divide by 1000, i.e. move the decimal point three places to the left. 500 mcg → 0.5 mg; 100 mcg → 0.1 mg; 1500 mcg → 1.5 mg.

mg → mcg: multiply by 1000, i.e. move the decimal point three places to the right. 0.5 mg → 500 mcg; 2 mg → 2000 mcg; 1.25 mg → 1250 mcg.

The tool above does the same move for you and trims trailing zeros, so you can paste in any value — whole or fractional — and read the exact counterpart.

Quick-reference table: mcg to mg

The most common research micrograms and their milligram equivalents. Read it in either direction.

100 mcg

0.1 mg

250 mcg

0.25 mg

500 mcg

0.5 mg

1000 mcg

1 mg

2500 mcg

2.5 mg

5000 mcg

5 mg

Is 1000 mcg the same as 1 mg?

Yes — exactly the same amount. One milligram is defined as one thousand micrograms, so 1000 mcg and 1 mg are two ways of writing an identical mass. By the same logic, 500 mcg is half a milligram (0.5 mg), and 2000 mcg is two milligrams. There is no rounding and no approximation involved; the equality is definitional.

Where this fits in the dosing math

This converter only changes units — it does not tell you what dose to use, and it is not a substitute for the compound-specific information on each protocol page. Its job is to hand the next step a clean number. Once your dose is expressed in milligrams, the peptide dosage calculator and the reconstitution calculator turn that milligram figure, your vial strength, and your bacteriostatic water into the exact volume and syringe units to draw. For the full reconstitution walk-through — water, sterility, storage and syringes — see the peptide reconstitution guide, and if a term here is unfamiliar, the peptide glossary defines it.

Keep the two jobs separate and the arithmetic stays trustworthy: this page converts units with certainty, and the compound-specific material handles what those units should be. Everything here is for research and educational use only and is not medical advice.

Frequently asked questions

There are 1000 micrograms in 1 milligram. The relationship is fixed: 1 mg = 1000 mcg. So to turn milligrams into micrograms you multiply by 1000, and to turn micrograms into milligrams you divide by 1000.

Yes, exactly. One milligram is defined as one thousand micrograms, so 1000 mcg and 1 mg are two ways of writing the identical amount. There is no rounding involved — the equality is definitional.

Divide the microgram value by 1000, which is the same as moving the decimal point three places to the left. For example, 250 mcg = 0.25 mg, 500 mcg = 0.5 mg, and 100 mcg = 0.1 mg.

Multiply the milligram value by 1000, which is the same as moving the decimal point three places to the right. For example, 0.5 mg = 500 mcg, 2 mg = 2000 mcg, and 1.25 mg = 1250 mcg.

250 mcg equals 0.25 mg. You divide 250 by 1000, which moves the decimal three places to the left. Common equivalents: 100 mcg = 0.1 mg, 500 mcg = 0.5 mg, and 1000 mcg = 1 mg.

Vials are labelled by their total mass in milligrams (for example, a 5 mg or 10 mg vial), while individual research doses are often a small fraction of a milligram and are quoted in micrograms to avoid leading zeros — 250 mcg reads more cleanly than 0.25 mg. Both describe the same quantity, which is why converting between them matters.

Yes. µg (the Greek letter mu followed by g) and mcg are two abbreviations for the microgram, the same unit of mass. Both equal one thousandth of a milligram, so 1 mg = 1000 µg = 1000 mcg.

No. This site is an independent research reference and this tool performs unit arithmetic only (1 mg = 1000 mcg). It does not recommend a dose or suggest that any substance be used in humans. What dose is appropriate for a given compound is a separate decision that belongs with documented sources and a qualified professional. Everything here is for research and educational use only.

Keep going

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01VK2735 — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 10 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 10 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. VK2735 is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗

02Cortexin — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 10 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 10 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Cortexin is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗

03P21 — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 10 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 10 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. P21 is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗

04Davunetide — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 5 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 5 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Davunetide is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗

05Retinalamin — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 5 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 5 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Retinalamin is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗

Research context

Read sources and limitations before applying a claim.

Safety and Tolerability in the Research Setting

Safety and efficacy are separate questions, and it is entirely possible for a compound to be well tolerated while remaining unproven for the condition of interest. That is the current situation for NAD+ precursors in Parkinson’s disease. The short-term tolerability data, particularly for oral nicotinamide riboside, are reassuring within the limits of the trials conducted, but they are not a statement about long-term safety, about frail or elderly populations over years, or about drug interactions in people taking multiple Parkinson’s medications. The most directly relevant safety dataset is NR-SAFE, which was explicitly designed to probe tolerability at a high dose. Over four weeks, 3,000 mg of NR daily produced only mild adverse events, with no moderate or severe events and no significant excess over placebo; the most frequently reported events in the NR arm included extrapyramidal symptoms, headache, tremor, muscle cramps, fatigue, nausea, and dyspepsia, several of which overlap with the underlying disease and its treatment.2 The absence of painful flushing is notable because flushing is a classic dose-limiting effect of nicotinic acid (niacin); NR and nicotinamide generally avoid the flushing that niacin causes, which is one reason they are favored for chronic dosing. The lower-dose NADPARK trial similarly reported that 1,000 mg daily was well tolerated over 30 days.1 Broader supplement-safety literature on NR in non-Parkinson populations has generally supported tolerability at commonly studied doses, and NMN has likewise been reported to raise blood NAD+ safely in short studies of healthy adults.13 These reassurances come with substantial caveats that a careful reader should hold in mind. First, the trials are small and short. Twenty participants over four weeks, or thirty over one month, cannot detect uncommon adverse events or effects that only emerge with months to years of exposure, which is exactly the exposure that disease modification would require. Second, the populations were selected: early-stage, often newly diagnosed patients able to participate in a trial, not the full spectrum of advanced disease, multimorbidity, and polypharmacy seen in practice. Third, theoretical concerns exist that have not been resolved in humans. Because NAD+ metabolism intersects with cell proliferation and with the kynurenine pathway, and because some preclinical work has raised tissue-specific concerns about chronic high-dose precursor exposure (for example, questions about metabolite accumulation with sustained oral NMN in animal models), long-term safety cannot be assumed from short-term tolerability.13 Fourth, methylation load is a plausible consideration: clearance of excess nicotinamide consumes methyl groups, and the metabolic consequences of chronically high precursor intake over years are not well characterized in this population. There is also the matter of source and quality. In a research context, the identity, purity, and endotoxin status of a compound materially affect both the validity of an experiment and the safety of any handling. Injectable NAD+ preparations used outside regulated trials vary widely in provenance, and intravenous NAD+ administration in particular has been associated with infusion-related discomfort (nausea, chest tightness, flushing) that is typically managed by slowing the infusion rate but underscores that route and formulation matter.4 None of this constitutes clinical guidance. The appropriate summary is that oral NR appears well tolerated in the short term at the doses tested in early Parkinson’s trials, that other precursors and routes have thinner safety records, and that long-term safety in Parkinson’s disease specifically remains unestablished pending completed, published, adequately long trials.

Source: dosagepeptide.com ↗

Handling and Reconstitution in a Research Context

Because AOD-9604 is most often encountered as a lyophilized (freeze-dried) powder in a sealed vial, a brief, strictly educational note on laboratory handling is warranted — with the emphasis that this is standard research-peptide practice, not a usage recommendation, and that AOD-9604 is not an approved therapeutic for any indication. Lyophilized peptides are generally reconstituted with sterile or bacteriostatic water for laboratory purposes. The diluent is directed slowly against the inside wall of the vial rather than sprayed onto the powder, and the vial is gently swirled rather than shaken, because vigorous agitation can shear peptide bonds and denature the material. The volume of diluent chosen simply sets the concentration: a fixed mass of peptide dissolved in a larger volume yields a lower concentration per unit volume, the arithmetic underlying any reconstitution chart. Standard stability and storage considerations recur across the research-peptide literature. Lyophilized storage Cool, dark conditions; long-term stability favored by freezing After reconstitution Refrigerated; used within a limited window Light and heat Minimize exposure; both can degrade peptides Agitation Swirl gently; avoid shaking or foaming Freeze-thaw Repeated cycles degrade peptides; avoid Sterility Aseptic technique; bacteriostatic water for multi-use practice It bears repeating that meticulous handling changes nothing about the evidence question. A perfectly reconstituted, high-purity vial of AOD-9604 is still a compound whose antilipogenic action is documented only preclinically and never quantified in humans. Good technique preserves whatever biological activity the molecule has; it does not create efficacy where none has been demonstrated. Researchers surveying how these compounds are cataloged can consult the site’s central dosages index, organized for educational reference rather than as guidance for human use.

Source: dosagepeptide.com ↗

Practical and safety references

These excerpts are educational, not personalised medical instructions.

How-to reference

How to Read the 3% to 10% SNAP-8 Range

The ingredient developer supplied SNAP-8 as a preserved aqueous blend containing approximately 0.05% acetyl octapeptide-3. Adding 3% to 10% of that solution gives 0.0015% to 0.005% actual peptide in the final product[6]. A raw 10 mg vial and a preserved commercial premix are not operationally interchangeable. 3% 0.05% 0.0015% 6% 0.0030% 10% 0.0050%

Source: peptidedosages.com ↗

Dosage reference

GHRP-2 (10mg Vial) Dosage Protocol

Ghrelin-receptor GH secretagogue — research/educational dosing reference.

Source: dosagepeptide.com ↗

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →